SG Americas Securities
GRNA

SG Americas Securities’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

SG Americas Securities’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,899
Closed -$18K – 3426
2023
Q1 		$18K Buy
+40,899
New +$31.4K ﹤0.01% 3166
2022
Q4 		– Sell
-12,488
Closed -$29K – 3471
2022
Q3 		$29K Buy
+12,488
New +$32.7K ﹤0.01% 3068

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

SG Americas Securities's GRNA Position: Q2 2023 in Review

SG Americas Securities sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 40,899 shares — an estimated $18K sold.

SG Americas Securities first reported a position in GRNA in Q3 2022 and held it in 2 quarters. The position peaked at $29K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

  • SG Americas Securities reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 40,899 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $18K.
  • SG Americas Securities first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 2 quarters.
  • SG Americas Securities's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $29K in Q3 2022.
  • 48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.